Innophos (IPHS) Stock Rating Lowered by BidaskClub

Innophos (NASDAQ:IPHS) was downgraded by investment analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued on Tuesday.

Several other equities analysts have also issued reports on the stock. KeyCorp reissued a “hold” rating on shares of Innophos in a report on Wednesday, November 1st. Zacks Investment Research lowered shares of Innophos from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 4th.

Shares of Innophos (NASDAQ IPHS) opened at $46.16 on Tuesday. The company has a current ratio of 2.86, a quick ratio of 1.49 and a debt-to-equity ratio of 0.83. Innophos has a fifty-two week low of $41.66 and a fifty-two week high of $58.22. The company has a market cap of $902.24, a price-to-earnings ratio of 18.78 and a beta of 0.86.

Innophos (NASDAQ:IPHS) last released its earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.78 EPS for the quarter, topping analysts’ consensus estimates of $0.72 by $0.06. Innophos had a net margin of 6.19% and a return on equity of 13.90%. The firm had revenue of $184.00 million during the quarter, compared to analyst estimates of $179.33 million. During the same quarter in the previous year, the business earned $0.69 EPS. The business’s quarterly revenue was down 1.1% compared to the same quarter last year. equities analysts forecast that Innophos will post 2.5 earnings per share for the current fiscal year.

Hedge funds have recently made changes to their positions in the company. Old Mutual Global Investors UK Ltd. acquired a new position in shares of Innophos in the 3rd quarter valued at $109,000. Public Employees Retirement System of Ohio grew its holdings in shares of Innophos by 5.9% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 2,824 shares of the specialty chemicals company’s stock valued at $124,000 after buying an additional 157 shares during the period. Macquarie Group Ltd. acquired a new position in shares of Innophos in the 3rd quarter valued at $193,000. Piedmont Investment Advisors LLC bought a new stake in Innophos in the 3rd quarter valued at $209,000. Finally, Pacad Investment Ltd. lifted its position in Innophos by 19.5% in the 2nd quarter. Pacad Investment Ltd. now owns 4,900 shares of the specialty chemicals company’s stock valued at $215,000 after acquiring an additional 800 shares in the last quarter. 94.46% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Innophos (IPHS) Stock Rating Lowered by BidaskClub” was first published by Community Financial News and is owned by of Community Financial News. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.com-unik.info/2017/12/05/innophos-iphs-stock-rating-lowered-by-bidaskclub.html.

Innophos Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

What are top analysts saying about Innophos Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Innophos Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit